Moxifloxacin-based triple therapy for helicobacter pylori eradication in type 2 diabetic patients
- VernacularTitle:莫西沙星三联疗法根除2型糖尿病患者幽门螺杆菌感染临床观察
- Author:
Shaozhen WANG
;
Yanan SHI
;
Bixiao CHEN
;
Jing ZHAO
;
Jinjin LI
;
Xinyu LIU
;
Lei GUO
;
Kun FU
;
Yanguang XU
- Publication Type:Journal Article
- Keywords: Diabetes mellitus; type 2; Helicobacter pylori
- From: Chinese Journal of General Practitioners 2009;8(8):563-565
- CountryChina
- Language:Chinese
- Abstract: Alc in trial group were significant better than those in control group ( P < 0. 05 ). The results indicate that type 2 diabetic patients with Hp infection should receive moxifloxacin-based triple therapy as first-line treatment.